Laura Sparving is M.Sc. in Pharmaceutical Sciences and has been with Billev Pharma since January 2019 as Pharmacovigilance Manager.
She has more than 10 years’ experience with Pharmacovigilance in post-marketing and clinical trials for human products within the following areas:
* Signal detection
* Writing of aggregated reports including Periodic Safety Update Report (PSURs), Development Safety Update Report (DSUR) and Risk Management Plan (RMP)
* Update of labelling documents
* Chair of Safety Management Teams
* Literature surveillance
* Individual case review
* Safety monitoring in clinical trials
* Investigator meetings
* Safety database upgrade
* Data entry of ICSRs
In addition, she has experience with regulatory affairs.